CD1A and cervical carcinoma: In their study on cervical cancer, Ren et al. [178] showed that CD1a+DCs loaded with HeLa-derived ExVs promoted T cell proliferation and induced cytotoxic responses to inhibit the growth of cervical cancer cells in vitro.